Development of novel treatment strategies for inflammatory diseases-similarities and divergence between glucocorticoids and GILZ.
Development of novel treatment strategies for inflammatory diseases-similarities and divergence between glucocorticoids and GILZ.
复制标题
DOI：
10.3389/fphar.2014.00169
复制
发表时间：
2014
影响因子：
5.6
通讯作者：
Yang YH
中科院分区：
文献类型：
--
作者：
Cheng Q;Morand E;Yang YH
Glucocorticoids (GC) are the most commonly prescribed medications for patients with inflammatory diseases, despite their well-known adverse metabolic effects. Previously, it was understood that the anti-inflammatory effects of the GC/GC receptor (GR) complex were mediated via transrepression, whilst the adverse metabolic effects were mediated via transactivation. It has recently become clear that this “divergent actions” paradigm of GC actions is likely insufficient. It has been reported that the GC/GR-mediated transactivation also contributes to the anti-inflammatory actions of GC, via up-regulation of key anti-inflammatory proteins. One of these is glucocorticoid-induced leucine zipper (GILZ), which inhibits inflammatory responses in a number of important immune cell lineages in vitro, as well as in animal models of inflammatory diseases in vivo. This review aims to compare the GILZ and GC effects on specific cell lineages and animal models of inflammatory diseases. The fact that the actions of GILZ permit a GILZ-based gene therapy to lack GC-like adverse effects presents the potential for development of new strategies to treat patients with inflammatory diseases.
登录
查看更多内容
DOI：
10.1073/pnas.1105857108
发表时间：
2011-11-29
影响因子：
11.1
作者：
Baschant, Ulrike;Frappart, Lucien;Tuckermann, Jan P.
通讯作者：
Tuckermann, Jan P.
影响因子：
4.8
作者：
Bruscoli, Stefano;Velardi, Enrico;Riccardi, Carlo
通讯作者：
Riccardi, Carlo
影响因子：
15.9
作者：
Ayroldi, Emira;Zollo, Ornella;Riccardi, Carlo
通讯作者：
Riccardi, Carlo
影响因子：
20.3
作者：
Cannarile, L;Fallarino, F;Riccardi, C
通讯作者：
Riccardi, C
影响因子：
56.9
作者：
AUPHAN, N;DIDONATO, JA;KARIN, M
通讯作者：
KARIN, M